Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers
P Michl, J Downward - Zeitschrift für Gastroenterologie, 2005 - thieme-connect.com
Zusammenfassung Die Phosphoinositol-3-OH-Kinase (PI3K) und die von ihr aktivierte
Serin/Threoninkinase Akt, auch als Proteinkinase B bekannt, sind wichtige Effektormoleküle …
Serin/Threoninkinase Akt, auch als Proteinkinase B bekannt, sind wichtige Effektormoleküle …
PI3K/Akt signalling pathway and cancer
JÁF Vara, E Casado, J de Castro, P Cejas… - Cancer treatment …, 2004 - Elsevier
Phosphatidylinositol-3 kinases, PI3Ks, constitute a lipid kinase family characterized by their
ability to phosphorylate inositol ring 3′-OH group in inositol phospholipids to generate the …
ability to phosphorylate inositol ring 3′-OH group in inositol phospholipids to generate the …
The PI3K pathway as drug target in human cancer
KD Courtney, RB Corcoran… - Journal of clinical oncology, 2010 - ascopubs.org
The phosphatidylinositol 3-kinase (PI3K) signaling axis impacts on cancer cell growth,
survival, motility, and metabolism. This pathway is activated by several different mechanisms …
survival, motility, and metabolism. This pathway is activated by several different mechanisms …
Portrait of the PI3K/AKT pathway in colorectal cancer
SA Danielsen, PW Eide, A Nesbakken, T Guren… - … et Biophysica Acta (BBA …, 2015 - Elsevier
Abstract PI3K/AKT signaling leads to reduced apoptosis, stimulates cell growth and
increases proliferation. Under normal conditions, PI3K/AKT activation is tightly controlled …
increases proliferation. Under normal conditions, PI3K/AKT activation is tightly controlled …
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions
The human body consists of countless cells with the possibility of excessive and
uncontrolled proliferation under certain dysregulated circumstances that could cause …
uncontrolled proliferation under certain dysregulated circumstances that could cause …
PI3K‐independent AKT activation in cancers: A treasure trove for novel therapeutics
K Mahajan, NP Mahajan - Journal of cellular physiology, 2012 - Wiley Online Library
AKT/PKB serine threonine kinase, a critical signaling molecule promoting cell growth and
survival pathways, is frequently dysregulated in many cancers. Although …
survival pathways, is frequently dysregulated in many cancers. Although …
Targeting PI3K/Akt signal transduction for cancer therapy
Y He, MM Sun, GG Zhang, J Yang, KS Chen… - Signal transduction and …, 2021 - nature.com
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various
cellular processes and is aberrantly activated in cancers, contributing to the occurrence and …
cellular processes and is aberrantly activated in cancers, contributing to the occurrence and …
Targeting PI3K signaling as a therapeutic approach for colorectal cancer
J Zhang, TM Roberts, RA Shivdasani - Gastroenterology, 2011 - Elsevier
Survival times of patients with colorectal cancer (CRC) have increased over the past
decade, primarily as a result of treatment with combinations of conventional cytotoxic agents …
decade, primarily as a result of treatment with combinations of conventional cytotoxic agents …
[HTML][HTML] PI3K and AKT: unfaithful partners in cancer
S Faes, O Dormond - International journal of molecular sciences, 2015 - mdpi.com
The phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway regulates multiple cellular
processes. An overactivation of the pathway is frequently present in human malignancies …
processes. An overactivation of the pathway is frequently present in human malignancies …
Mice expressing activated PI3K rapidly develop advanced colon cancer
AA Leystra, DA Deming, CD Zahm, M Farhoud… - Cancer research, 2012 - AACR
Aberrations in the phosphoinositide 3-kinase (PI3K) signaling pathway play a key role in the
pathogenesis of numerous cancers by altering cellular growth, metabolism, proliferation …
pathogenesis of numerous cancers by altering cellular growth, metabolism, proliferation …